https://www.avient.com/resources/safety-data-sheets?page=5069
MAROON UV
UV UNIVERSAL GREY
BLUE W/EZE V3
https://www.avient.com/resources/safety-data-sheets?page=4137
UV BLUE 3005C PP
AMBER YELLOW UV
REVEAL GREY W/AS
https://www.avient.com/resources/safety-data-sheets?page=7042
TPU TR PURPLE 7441C W/20% BASO4
ORANGE TPU UV
BLACK UV 7
https://www.avient.com/resources/safety-data-sheets?page=1581
M W BURGUNDY
UV Bandlock White
UV-CC
https://www.avient.com/resources/safety-data-sheets?page=1187
WHITE w/o UV M6291B
UV WHITE WALL M6306-1
PG 109124.01 RD PP UV
https://www.avient.com/resources/safety-data-sheets?page=5640
KX4 WHITE W/BLACK SPECKS
GUN METAL UV FOR GP22
UV BRT YELLOW PP 2%
https://www.avient.com/sites/default/files/2024-03/AVNT February IR Presentation_w_Non-GAAP Recs_v2.pdf
Continue fostering our Great Place to Work® culture Strategic Objectives Long Term Growth Rates Growth Drivers $340 $455 $790 $1,135 2016 2018 2020 2023 $51 $84 $212 $645 2016 2018 2020 2023 $108 $113 $231 $230 2016 2018 2020 2023 $265 $358 $726 $725 2016 2018 2020 2023 8-12% 8-10% 8-10% 5% Sustainable Solutions Composites Healthcare Asia/Emerging Regions Profitable Growth Great Place to Work 5.4% 10.9% 16.0% 2006 2014 2023 EBITDA Margins $0.14 $1.93 $2.36 2006 2014 2023 Adjusted EPS TOP-TIER SUSTAINABILITY PERFORMANCE AND RECOGNITION Industry Sustainability Standards ESG Ratings Performance 1 2 4 87th 94th percentile 5 Avient CDP Score: A- FE BRUARY 14 , 2024 W E BCAS T P RE S E N TAT I O N DR.
https://www.avient.com/sites/default/files/2024-08/Avient AUG 2024 Investor Presentation- w Non-GAAP.pdf
& Canada EMEA Asia Latin America 64% 36% Specialty Engineered Materials Color Additives and Inks 41% 36% 18% 5% 7% 7% 23% 19% 9% 16% 10% 5% 4% Defense Healthcare Packaging Consumer Building & Construction Industrial Transportation Energy Telecom Geography Segment Industry 2024 Financial Guidance $515 to $540 million Adjusted EBITDA $2.55 to $2.70 Adjusted EPS 4 Industry Sustainability Standards ESG Ratings Performance 1 2 4 87th 94th percentile Avient CDP Score: A- SUSTAINABILITY PERFORMANCE AND RECOGNITION AU G U S T 6 , 20 24 W EB CAS T P RE SE N TATI O N 6 Q2 2024 HIGHLIGHTS • 5% organic sales growth supported by broad-based growth across all regions in both CAI and SEM segments • Growth stemmed from gaining share, winning new product specifications and restocking in certain end markets • Cost control and operational discipline expanded EBITDA margins by 100 bps • EPS exceeded guidance by $0.05 and increased 21% vs the prior year Adj.
https://www.avient.com/sites/default/files/2024-10/2024 AVNT Q3 Webcast Slides w appendix and non-GAAP.pdf
Three Months Ended September 30, 2024 2023 Reconciliation to Condensed Consolidated Statements of Income $ EPS(1) $ EPS(1) Net income from continuing operations attributable to Avient shareholders $ 38.2 $ 0.41 $ 5.1 $ 0.06 Special items, after-tax 6.6 0.07 32.0 0.35 Amortization expense, after-tax 15.0 0.16 15.2 0.16 Adjusted net income / EPS $ 59.8 $ 0.65 $ 52.3 $ 0.57 (1) Per share amounts may not recalculate from figures presented herein due to rounding Three Months Ended September 30, Reconciliation to EBITDA and Adjusted EBITDA: 2024 2023 Net income from continuing operations – GAAP $ 38.7 $ 5.1 Income tax expense (benefit) 11.3 (0.1) Interest expense, net 26.9 30.3 Depreciation & amortization 45.1 46.4 EBITDA from continuing operations $ 122.0 $ 81.7 Special items, before tax 9.7 43.2 Interest expense included in special items (1.3) (2.2) Depreciation & amortization included in special items (0.4) — Adjusted EBITDA $ 130.0 $ 122.7 Adjusted EBITDA as a percent of sales 15.9 % 16.3 % 1 Three Months Ended September 30, 2024 2023 Sales: Color, Additives and Inks $ 521.5 $ 486.5 Specialty Engineered Materials 294.6 267.9 Corporate (0.9) (0.7) Sales $ 815.2 $ 753.7 Operating income: Color, Additives and Inks $ 75.5 $ 64.5 Specialty Engineered Materials 36.4 30.3 Corporate (34.7) (60.5) Operating income $ 77.2 $ 34.3 Depreciation & amortization: Color, Additives and Inks $ 21.9 $ 24.6 Specialty Engineered Materials 20.7 20.5 Corporate 2.5 1.3 Depreciation & amortization $ 45.1 $ 46.4 Earnings before interest, taxes, depreciation and amortization (EBITDA): Color, Additives and Inks $ 97.4 $ 89.1 Specialty Engineered Materials 57.1 50.8 Corporate (32.2) (59.2) Other (expense) income, net (0.3) 1.0 EBITDA from continuing operations $ 122.0 $ 81.7 Special items, before tax 9.7 43.2 Interest expense included in special items (1.3) (2.2) Depreciation & amortization included in special items (0.4) — Adjusted EBITDA $ 130.0 $ 122.7 Adjusted EBITDA as a percent of sales: Color, Additives and Inks 18.7 % 18.3 % Specialty Engineered Materials 19.4 % 19.0 % 2 Year Ended December 31, 2023 Operating income: Color, Additives and Inks $ 259.9 Specialty Engineered Materials 142.5 Corporate (205.6) Operating income $ 196.8 Depreciation & amortization: Color, Additives and Inks $ 98.3 Specialty Engineered Materials 81.5 Corporate 9.0 Depreciation & amortization $ 188.8 Earnings before interest, taxes, depreciation and amortization (EBITDA): Color, Additives and Inks $ 358.2 Specialty Engineered Materials 224.0 Corporate (196.6) Other income, net 5.8 EBITDA from continuing operations 391.4 Special items, before tax 114.6 Interest expense included in special items (2.3) Depreciation & amortization included in special items (1.9) Adjusted EBITDA $ 501.8 3 Avient Q3 Earnings Webcast Slides w_Appendix and Non-GAAP.pdf 2024 AVNT Q3 Webcast Slides w non-GAAP.pdf Q3 Avient Webcast Slides with Non-GAAP Recs.pdf Appendix Slides for webcast.pdf IR Deck - AVNT-2024.09.30 - 10.30.24 3PM (002).pdf Attachment
https://www.avient.com/sites/default/files/2023-01/Mevopur Healthcare Functional Additives Chemical Foaming Agents Application Bulletin.pdf
KEY CHARACTERISTICS • Manufactured under ISO 13485 procedures • Documented change control beyond CAS number, reducing risk of change • Can be used on common injection molding and extrusion machines—set-up support by a technical assistance team • Available for use in polyolefins, styrenics and copolymers • Can be combined with colorants REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 - USP and (incl. class VI) - European Pharmacopeia, monograph 3.1.3/ 3.1.5 (polyolefin packaging materials) - USP (polyethylene) - Elemental impurities as per ICH Q3D • Registered Drug Master File (Type III) and/or Device Master File • Food contact according to USA FDA and EU norms APPLICATION BULLETIN Sustainability Spotlight Healthcare use limitations apply—see below.